168 related articles for article (PubMed ID: 25180836)
1. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma.
Fang Y; Yi J; Lizhi L; Qiucheng C
DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836
[TBL] [Abstract][Full Text] [Related]
2. RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.
Niu H; Wu B; Peng Y; Jiang H; Zhang Y; Wang J; Zhang Y; He P
Tumour Biol; 2015 Jan; 36(1):409-19. PubMed ID: 25266803
[TBL] [Abstract][Full Text] [Related]
3. Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.
Yi B; Hu Y; Qin G; Gu W; Zhu X; He S; Zhou J; Li D
Int J Mol Med; 2014 Jul; 34(1):205-12. PubMed ID: 24788627
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
5. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
6. miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs.
Liao CG; Kong LM; Zhou P; Yang XL; Huang JG; Zhang HL; Lu N
J Transl Med; 2014 Sep; 12():234. PubMed ID: 25236186
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
11. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
12. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
13. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.
Sun F; Wang J; Sun Q; Li F; Gao H; Xu L; Zhang J; Sun X; Tian Y; Zhao Q; Shen H; Zhang K; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):449. PubMed ID: 31684995
[TBL] [Abstract][Full Text] [Related]
15. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
16. Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways.
Cong N; Li Z; Shao W; Li J; Yu S
J Membr Biol; 2016 Apr; 249(1-2):119-28. PubMed ID: 26501871
[TBL] [Abstract][Full Text] [Related]
17. Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Yang F; Lv L; Zhang K; Cai Q; Liu J; Jiang Y
Cell Physiol Biochem; 2017; 44(1):99-109. PubMed ID: 29131008
[TBL] [Abstract][Full Text] [Related]
18. RNA interference targeting human integrin α6 suppresses the metastasis potential of hepatocellular carcinoma cells.
Lv G; Lv T; Qiao S; Li W; Gao W; Zhao X; Wang J
Eur J Med Res; 2013 Dec; 18(1):52. PubMed ID: 24304619
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of RhoGDI2 correlates with the progression and prognosis of pancreatic carcinoma.
Yi B; Zhang Y; Zhu D; Zhang L; Song S; He S; Zhang B; Li D; Zhou J
Oncol Rep; 2015 Mar; 33(3):1201-6. PubMed ID: 25573518
[TBL] [Abstract][Full Text] [Related]
20. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
